192869-57-1

Basic information

• Product Name: 2-Amino-5-(benzyloxy)-4-methoxybenzonitrile
• Synonyms: 2-Amino-5-(benzyloxy)-4-methoxybenzonitrile
• CAS NO: 192869-57-1
• Molecular Formula: C₁₅H₁₄N₂O₂
• Molecular Weight: 254.28
• Mol File: 192869-57-1.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 452.32°C at 760 mmHg
• Flash Point: 227.355°C
• Appearance: /
• Density: 1.222g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.612
• PKA: 1.95±0.10(Predicted)
• CAS DataBase Reference: 2-Amino-5-(benzyloxy)-4-methoxybenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-5-(benzyloxy)-4-methoxybenzonitrile(192869-57-1)
• EPA Substance Registry System: 2-Amino-5-(benzyloxy)-4-methoxybenzonitrile(192869-57-1)

Safety Data

• Hazardous Substances Data: 192869-57-1(Hazardous Substances Data)

Usage

Physical state

white to off-white solid

Solubility

slightly soluble in water, more soluble in organic solvents

Molecular weight

277.3 g/mol

Common uses

intermediate in pharmaceutical and organic compound synthesis

Potential applications

pharmaceutical and chemical industries

Versatility

used in production of drugs and other chemical products

InChI:InChI=1/C15H14N2O2/c1-18-14-8-13(17)12(9-16)7-15(14)19-10-11-5-3-2-4-6-11/h2-8H,10,17H2,1H3

Upstream product

• 192869-56-0 5-benzyloxy-4-methoxy-2-nitro-benzonitrile 
• 1112-67-0 tetrabutyl-ammonium chloride 
• 621-59-0 isovanillin 
• 100-39-0 benzyl bromide 
• 52805-46-6 2-methoxy-5-cyanophenol 

Downstream Products

• 913819-12-2 6-(benzyloxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine 
• 184475-71-6 4-(3-chloro-4-fluorophenylamino)-6-hydroxy-7-methoxyquinazoline 

Relevant articles and documents

4-anilinoquinazoline derivative and albumin conjugates thereof

a pharmaceutical composition for preventing, treating, or ameliorating one or more symptoms of a malignant tumor associated with EGFR mutation and/or K-RAS mutation is provided. The pharmaceutical composition includes a 4-anilinoquinazoline derivative having a formula (I) where A is iodine when m is 1 and n is zero, or A is albumin when m is an integral ranging from 1 to 7 and n is 1.

PROCESS FOR PREPARING QUINAZOLINE DERIVATIVE

A concise, efficient and cost-and time-saving process for the preparation of a quinazoline derivative of formula (A) given below: which is an intermediate for making gefitinib or gefitinib itself, comprising reacting a compound of formula (B): with 3-chloro-4-fluoroaniline (VI) in the presence of a N,N-dialkyl formamide acetal, a Bronsted acid catalyst, and a solvent in a one-pot reaction.

Quinoline and quinazoline compounds useful in therapy

Compounds of formula I, wherein R1 represents C1-4 alkoxy optionally substituted by one or more fluorine atoms; R2 represents an aryl group or a heteroaryl group, optionally substituted by C1-4 alkyl or SO2